Pulse Newsletter
Browse page 10 of our Pulse Newsletter articles in the Thrivous Views blog at Thrivous. They're listed below. If you prefer, you can also browse all articles in Thrivous Views. Or search for articles and other content on the Thrivous website.
-
Exercise for Blood Flow to the Brain and Better Aging
Researchers at UT Southwestern have reported their observations of older adults with mild memory loss who followed a physical exercise ...
-
Cheap FDA-Approved Drug May Be an Ideal COVID-19 Treatment
Scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong have found that the drug clofazimine exhibits ...
-
Gene Therapy for Back Pain and Other Chronic Pain
Researchers at UC San Diego have developed a gene therapy strategy for chronic pain. It may provide better results than alternatives such ...
-
TAME Trial May Set Anti-Aging Drug Precedent
An FDA-approved drug has been used successfully to treat type 2 diabetes for more than 60 years. Studies have already ...
-
New Uses for Botox to Edit the Proteome
Researchers at Harvard University and Broad Institute have shown that botulinum toxin proteins can be engineered to enable new medical applications. ...
-
Designing Biomaterials for 3D Printing "Walking Molecules"
Northwestern University researchers have discovered a new synthetic biomaterial that can mimic properties of brain tissue. The biomaterial is suitable ...
-
An Artificial System Inspired by Dogs Smells Disease
Researchers at MIT and other institutions have developed a miniaturized detection system that seems to detect diseases with even greater ...
-
Can a New Pill Treat Obesity?
About one third (35%) of people who took a new drug for treating obesity lost more than one-fifth of their ...
-
Personalized Brain Stimulation Therapies
Researchers at University of Southern California (USC) are advancing toward personalized deep brain stimulation. This research could open the doors ...
-
What Is Chinese Vaccine BBIBP-CorV?
Many people all over the world are likely to receive the COVID-19 vaccine BBIBP-CorV, developed by the Chinese state-owned biopharmaceutical ...
